# Antibiotic Resistance Pattern and Surgical Outcome in Complicated Intra-Abdominal Infections Due to Colorectal Perforation

**Authors:** Jacopo Giuliani, Camilla Cremonini, Serena Musetti, Giuseppe Zocco, Ismail Cengeli, Dario Tartaglia, Massimo Chiarugi, Alice Salamone, Ettore Melai, Francesco Forfori, Benedetta Tuvo, Iacopo Franconi, Antonella Lupetti, Lorenzo Ghiadoni, Federico Coccolini

PMC · DOI: 10.3390/antibiotics15020147 · Antibiotics · 2026-02-02

## TL;DR

This study examines antibiotic resistance and surgical outcomes in intra-abdominal infections caused by colorectal perforation, finding that resistant bacteria and polymicrobial infections increase hospital stays but not mortality.

## Contribution

The study provides insights into the relationship between antibiotic resistance patterns and surgical outcomes in complicated intra-abdominal infections due to colorectal perforation.

## Key findings

- Polymicrobial infections and multi-drug-resistant organisms are linked to longer hospital stays.
- Documented intra-abdominal infections are associated with prolonged postoperative hospitalization.
- Antibiotic resistance rates exceed 20% for many pathogens, but do not directly affect mortality.

## Abstract

Background: Intra-abdominal infections (IAIs) are one of the leading causes of non-traumatic death in emergency surgery units. The appropriateness of empirical antibiotic therapy is fundamental for outcomes and for limiting the spread of resistance. This study aimed to assess the epidemiology and antibiotic resistance patterns of microorganisms recovered from complicated intra-abdominal infections due to colorectal perforation at an Italian University Hospital during a nine-year period. Methods: This study evaluated a cohort of patients subjected to emergency surgery for colonic perforation with collected intrabdominal fluid samples from 2015 to 2024. Patterns of isolated bacteria and antibiotic resistance status were collected and correlated to patient outcomes. Results: 321 patients were enrolled; the average age was 70.2 years. The main diagnoses were complicated diverticulitis (58%), colorectal carcinoma perforation (18%), and acute intestinal ischemia (24%). 80.4% were immunocompromised; average hospital stay (HLOS) was 15.6 days; 60.1% developed postoperative complications. Microbiological cultures were available for 111 patients: 56.7% had mono-microbial infections and 43.3% multi-microbial infections. 53 antibiotics and 9 antifungals were tested, with resistance rates exceeding 20% for many pathogens. Multivariate analyses showed that documented IAIs are associated with longer postoperative hospital stays (p 0.003 CR 8.075) but not with patient mortality (p 0.031). Prolonged HLOS was more commonly observed in patients with polymicrobial infections or infections caused by multi-drug-resistant organisms (p 0.03; p 0.003). Conclusions: Microbiological characteristics of isolated bacteria do not directly influence mortality; however, the presence of polymicrobial infections and resistant pathogens directly affects the duration of hospitalization and often leads to the development of chronic disease conditions.

## Linked entities

- **Diseases:** acute intestinal ischemia (MONDO:0004613)

## Full-text entities

- **Diseases:** urinary tract infections (MESH:D014552), Infections (MESH:D007239), peritonitis (MESH:D010538), postoperative complications (MESH:D011183), Mortality (MESH:D003643), Colorectal Perforation (MESH:D015179), colonic ischemia (MESH:D003108), diverticular (MESH:D000076385), sepsis (MESH:D018805), septic shock (MESH:D012772), intra-abdominal fungal infections (MESH:D009181), necrosis (MESH:D009336), intestinal ischemia (MESH:D007410), septic (MESH:D001170), perforation (MESH:D057112), bacterial infections (MESH:D001424), carcinoma (MESH:D009369), IAIs (MESH:D059413), diverticulitis (MESH:D004238), ischemic (MESH:D002545), complications (MESH:D008107), peritoneal inflammation (MESH:D007249), abscess (MESH:D000038), injury to (MESH:D014947), critical illness (MESH:D016638), bowel ischemia (MESH:D007511), microbial infections (MESH:D015163), multi-organ dysfunction (MESH:D009102)
- **Chemicals:** amikacin (MESH:D000583), fluoroquinolones (MESH:D024841), Cephalosporins (MESH:D002511), piperacillin-tazobactam (MESH:D000077725), ceftazidime-avibactam (MESH:C000595613), nitrofurantoin (MESH:D009582), penicillins (MESH:D010406), beta-lactams (MESH:D047090), cefazolin (MESH:D002437), fluconazole (MESH:D015725), imipenem (MESH:D015378), ciprofloxacin (MESH:D002939), Azole (MESH:D001393), tigecycline (MESH:D000078304), amoxicillin/clavulanate (MESH:D019980), Aminoglycosides (MESH:D000617), ceftolozane-tazobactam (MESH:C000594038), cefoxitin (MESH:D002440), Doxycycline (MESH:D004318), amoxicillin (MESH:D000658), gentamicin (MESH:D005839), echinocandins (MESH:D054714), ceftazidime (MESH:D002442), carbapenems (MESH:D015780), cefepime (MESH:D000077723), levofloxacin (MESH:D064704), water (MESH:D014867)
- **Species:** Candida [taxon 1535326], Homo sapiens (human, species) [taxon 9606], Staphylococcus (genus) [taxon 1279], Lodderomyces parapsilosis (species) [taxon 5480], Streptococcus (genus) [taxon 1301], Citrobacter freundii (species) [taxon 546], Serratia marcescens (species) [taxon 615], Enterobacteriaceae (enterobacteria, family) [taxon 543], Klebsiella pneumoniae (species) [taxon 573], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Pseudomonas aeruginosa (species) [taxon 287], Nakaseomyces glabratus (species) [taxon 5478], Escherichia coli (E. coli, species) [taxon 562], Candida albicans (species) [taxon 5476]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937192/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937192/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937192/full.md

---
Source: https://tomesphere.com/paper/PMC12937192